Regulation as a Catalyst with Jonathan Bush and Chris Severn
Jun 25, 2024
auto_awesome
Jonathan Bush and Chris Severn discuss how regulatory changes impacted their companies' innovations, emphasizing the importance of collaborating with policymakers. They delve into navigating price transparency regulations and creating a competitive advantage in healthcare. The episode also explores evolving strategies in the market, the CEO's role in compliance, and potential future disruptions in the healthcare industry.
Regulatory change can catalyze company creation for founders.
Staying nimble and leveraging regulatory shifts are crucial for maintaining competitive advantages in healthcare.
Deep dives
Exploring Unknowns in Science, Society, and Life
Delving into the unknown realms, the podcast challenges conventional knowledge by highlighting mysteries like the functioning of bikes, the origin of the moon, and the definition of life. It pushes the boundaries of knowledge and continues to unravel uncertainties beyond our current understanding.
Regulatory Impact on Community Building and Policy Implementation
The episode features insight from industry experts like Jonathan Bush and Chris Severn, who discuss the influence of regulatory changes on company creation. Emphasizing the importance of aligning with government policymakers, they shed light on the role of regulations in catalyzing healthcare innovations and company development.
Navigating Regulatory Waters for Company Formation
With a focus on price transparency and interoperability, the conversation delves into how Turquoise Health and Zeus strategically leverage federal rules like the 21st Century Cures Act. They illustrate how seizing regulatory opportunities led to the inception of their companies, showcasing the significance of adapting to evolving regulations and creating unique value propositions.
Evolving Strategies for Compliance and Market Positioning
Amid evolving regulations like price transparency laws and interoperability requirements, companies like Turquoise and Zeus continually reassess their market positioning strategies. They emphasize the importance of staying nimble, identifying current rights to win, and effectively leveraging regulatory shifts to maintain competitive advantages and adapt to changing healthcare landscapes.
Jonathan Bush, founder and CEO of Zus Health, and Chris Severn, cofounder and CEO of Turquoise Health, join Julie Yoo, general partner, and Colin Rom, head of public policy for a16z Bio + Health.
We’ve long believed that regulatory change can be a catalyst for company creation. In this episode, Jonathan and Chris detail how that was true for them. They also outline a few key takeaways for founders hoping to leverage regulatory change themselves.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode